Literature DB >> 17940835

Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease.

Akifumi Kuwabara1, Haruhiko Okamoto, Takeyasu Suda, Yoichi Ajioka, Katsuyoshi Hatakeyama.   

Abstract

BACKGROUND: In this study we aimed to identify clinically relevant patterns of cytomegalovirus (CMV) infection in inflammatory bowel disease.
METHODS: Twenty-two patients with severe ulcerative colitis (UC), 12 with moderate UC, and 16 with Crohn's disease were studied retrospectively. We confirmed CMV infection immunohistochemically. The patients were classified into three groups according to the density of CMV-infected cells. Clinicopathologic features were compared between the groups.
RESULTS: Dense CMV infection was found only in five patients with severe UC. Scattered CMV infection was found in nine patients with severe UC, three with moderate UC, and one patient with Crohn's disease, and in three controls (normal mucosa from early colorectal cancer specimens). For patients with severe UC, severity of CMV infection tended to correlate with older age and more rapid deterioration, including toxic megacolon and panperitonitis. The dense CMV group took significantly higher final daily doses of steroids before the operation, and showed steroid resistance. The frequency of emergency surgery was higher and postoperative hospital stay was significantly longer in the dense CMV group. No significant differences were observed in sex, disease duration, steroid administration (total amount or duration), or frequencies of other therapies among the three groups. Immunohistochemically, CMV positivity in endothelial cells around the ulcer base was a significant feature in dense CMV infection, compared with scattered CMV infection.
CONCLUSIONS: Older patients with severe steroid-resistant UC may be at particular risk for CMV infection. Dense CMV infection, especially when it occurs predominantly in endothelial cells, may be a useful marker for clinically relevant CMV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940835     DOI: 10.1007/s00535-007-2103-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  18 in total

Review 1.  Host resistance and the immune system.

Authors:  A Ben-Yehuda; M E Weksler
Journal:  Clin Geriatr Med       Date:  1992-11       Impact factor: 3.076

2.  Cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  R Vega; X Bertrán; M Menacho; E Domènech; V Moreno de Vega; M Hombrados; E Cabré; I Ojanguren; M A Gassull
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

3.  Alimentary tract lesions in cytomegalovirus infection.

Authors:  T Iwasaki
Journal:  Acta Pathol Jpn       Date:  1987-04

4.  Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis.

Authors:  M Cottone; G Pietrosi; G Martorana; A Casà; G Pecoraro; L Oliva; A Orlando; M Rosselli; A Rizzo; L Pagliaro
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

5.  Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study.

Authors:  Neeraja Kambham; Rohini Vij; Christine A Cartwright; Teri Longacre
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

6.  The procoagulant response of cytomegalovirus infected endothelial cells.

Authors:  M C van Dam-Mieras; A D Muller; V W van Hinsbergh; W J Mullers; P H Bomans; C A Bruggeman
Journal:  Thromb Haemost       Date:  1992-09-07       Impact factor: 5.249

7.  Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection.

Authors:  H S Cooper; E C Raffensperger; L Jonas; W T Fitts
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

8.  Increase of interleukin 2 receptor and CD45RO antigen on lymphocytes cultured with human cytomegalovirus.

Authors:  T Nakano; M Ito; T Mizuno; K Mizutani; T Ihara; H Kamiya; M Sakurai
Journal:  Cell Immunol       Date:  1993-03       Impact factor: 4.868

9.  Cytomegalovirus infection of the colon: a possible role in exacerbations of inflammatory bowel disease.

Authors:  T Berk; S J Gordon; H Y Choi; H S Cooper
Journal:  Am J Gastroenterol       Date:  1985-05       Impact factor: 10.864

10.  Prevalence of cytomegalovirus infection in inflammatory bowel disease patients.

Authors:  Yoshihisa Takahashi; Tsuyoshi Tange
Journal:  Dis Colon Rectum       Date:  2004-03-25       Impact factor: 4.585

View more
  22 in total

1.  Cytomegalovirus in inflammatory bowel disease: A systematic review.

Authors:  Tessa E H Römkens; Geert J Bulte; Loes H C Nissen; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Cytomegalovirus, inflammatory bowel disease, and anti-TNFα.

Authors:  Sara T Campos; Francisco A Portela; Luís Tomé
Journal:  Int J Colorectal Dis       Date:  2017-01-13       Impact factor: 2.571

3.  Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes.

Authors:  Jeffrey D McCurdy; Edward V Loftus; William J Tremaine; Thomas C Smyrk; David H Bruining; Darrell S Pardi; Laura E Raffals; John B Kisiel; Nayantara Coelho-Prabhu; Sunanda V Kane; William A Faubion; Konstantinos A Papadakis
Journal:  Inflamm Bowel Dis       Date:  2013-10       Impact factor: 5.325

4.  CMV in moderately active colitis: much ado about nothing?

Authors:  Alan C Moss
Journal:  Dig Dis Sci       Date:  2010-04       Impact factor: 3.199

5.  Cytomegalovirus Reactivation in Ulcerative Colitis Patients.

Authors:  Minh Nguyen; Kara Bradford; Xiaolan Zhang; David Q Shih
Journal:  Ulcers       Date:  2011-01-01

6.  Cytomegalovirus infection and steroid-refractory inflammatory bowel disease: possible relationship from an updated meta-analysis.

Authors:  Chen-Chen Liu; Shusheng Ji; Yuanyuan Ding; Lili Zhou; Xiangyu Liu; Wen Li
Journal:  Ir J Med Sci       Date:  2018-02-01       Impact factor: 1.568

7.  Characteristic endoscopic findings and risk factors for cytomegalovirus-associated colitis in patients with active ulcerative colitis.

Authors:  Yutaka Hirayama; Takafumi Ando; Yoshiki Hirooka; Osamu Watanabe; Ryoji Miyahara; Masanao Nakamura; Takeshi Yamamura; Hidemi Goto
Journal:  World J Gastrointest Endosc       Date:  2016-03-25

Review 8.  Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.

Authors:  Sylvie Pillet; Bruno Pozzetto; Xavier Roblin
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

9.  Cytomegalovirus infection in patients with active inflammatory bowel disease.

Authors:  John J Kim; Nicole Simpson; Nancy Klipfel; Renee Debose; Nancy Barr; Loren Laine
Journal:  Dig Dis Sci       Date:  2010-01-29       Impact factor: 3.199

10.  Prognostic factors for colectomy in refractory ulcerative colitis treated with calcineurin inhibitors.

Authors:  Shigeki Bamba; Akira Andoh; Hirotsugu Imaeda; Hiromitsu Ban; Ayako Kobori; Yousuke Mochizuki; Makoto Shioya; Takashi Nishimura; Osamu Inatomi; Masaya Sasaki; Yasuharu Saitoh; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  Exp Ther Med       Date:  2012-04-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.